Logo
B

Bionanoplus

11 employees

Bionanoplus focuses on the development of polymeric nanoparticles and microparticles as controlled release drug delivery systems.

Basic info

Industry

nanotechnology research

Sectors

Biotechnology
IVRT
Encapsulation
Franz Diffusion Cells
Disruptive Technology
Drug Delivery
Health Diagnostics
Skin
Health Care
Agriculture
Onychomycosis
Vaccination
Polymeric nanoparticles
Dermatology
Smart textiles
Controlled Release
Hair Loss
Nanotechnology
Intellectual property
Innovation

Date founded

2010

Funding rounds raised

Total raised

$818K

from 2 investors over 2 rounds

B

Bionanoplus raised $818K on February 19, 2011

Investors: Start Up Capital Navarra, S.A. and Inveready

FAQ